Carbone Comprehensive Cancer Center. Various other potential mechanisms include prevention of fat gain, regulation of insulin sensitivity and alterations in immune function. Scientists from the National University of Singapore have discovered a biomarker, called adenosine deaminase acting on RNA-1 , which has the potential to boost the diagnosis, prognosis and treatment of the disease. Led by Dr Polly Chen from the Malignancy Research Institute of Singapore at NUS, the team is also the first ever to demonstrate that the editing of protein-producing sequences promotes the advancement of ESCC. December 2013 This novel research was first published online in Cancer Research on 4. Related StoriesCrucial transformation in single DNA base predisposes children to aggressive type of cancerViralytics enters into clinical trial collaboration agreement with MSDFDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLC Currently, there is normally poor prognosis for ESCC individuals and the five-year overall survival price ranges from 20 to 30 percent.The AGA Institute remains committed to providing young researchers with unprecedented research possibilities, said Nicholas F. LaRusso, MD, AGAF, chair of the AGA Analysis Foundation. We are really impressed by the caliber of nominations we received for the 2013 Student Analysis Fellowship Awards, and we look forward to watching these gifted learners because they work to progress the understanding of digestive illnesses through their novel analysis goals. Related StoriesMagnetizing biomolecules: an interview with Dr. Fred Whipple, AMSBIOBRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical SchoolIdentifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine A total of eight awards of $2,500 each were given to support high school students interested in executing digestive disease or nutrition research for a minimum of 10 weeks.